each case with and without clavulanic acid (AB Biodisk, Solna, Sweden). AmpC production was suspected in the absence of clavulanic acid potentiation of cephalosporins and additional resistance to cefoxitin. Pulsed-field gel electrophoresis (PFGE) was performed by the PulseNet method with Xba⌱ and Bln⌱, and the results were analyzed using Bionumerics software (Applied Maths, Saint-Martens-Latem, Belgium). Plasmids were prepared as previously described (20) and visualized on 0.7% Tris-acetate-EDTA gels by staining with 1 mg/ml ethidium bromide. Size was estimated using a standard curve constructed from plasmids from strains NCTC 50012 (72 MDa), NCTC 50001 (62 MDa), NCTC 50083 (126 MDa), and NCTC 50005 (26 MDa). Conjugation was carried out using the method of Hasman et al. (13) . A plasmid-free, amoxicillin-susceptible, and nalidixic acid-and rifampin-resistant Salmonella enterica serovar Dublin isolate was the recipient for mating experiments. Transconjugants were selected on LB agar plates containing cefoxitin (32 g/ml) and nalidixic acid (50 g/ml) or ampicillin (32 g/ml) and nalidixic acid (50 g/ml). Genomic DNA was extracted with a QIAamp DNA minikit (Qiagen, Inc., Valencia, CA). Absence of inhibitors of PCR was confirmed by amplification of 16S rRNA and the 23S rRNA spacer region (2) . PCR amplifications with specific primers for bla TEM , bla SHV , and bla CTX-M groups 1, 2, 8, 9, and 25; plasmid-mediated bla ampC (sequencing of positive amplicons by using primers specific for the entire bla CMY gene); Salmonella genomic island 1 (SGI1); and class 1 integrons were performed as previously described (11, 14, 15, 18, 22) . Positive amplicons were sequenced by Sequiserve, Vaterstetten, Germany.
The results are summarized in Table 1 . Plasmid-mediated ␤-lactamase gene bla CMY-2 was detected in 3 isolates and bla SHV-12 in 4. bla CMY-2 has been reported to occur in Salmonella but has not previously been reported to occur in S. Kentucky isolates from poultry. bla has been reported to occur in S. Kentucky from a human isolate (7) but not in that from poultry. All isolates contained two plasmids of ca. 4.9 and ca. 130 kb. In all cases, cephalosporin resistance was readily transferable, with cotransfer of both the ca. 4.9-kb and the ca. 130-kb plasmids in every case. bla SHV was detected by PCR in the ca. 4.9-kb plasmid but not in the ca. 130-kb plasmid in isolates with the SHV phenotype, while bla CMY was detected in the ca. 130-kb plasmid but not in the ca. 4.9-kb plasmid in isolates with the AmpC phenotype. The associations of bla SHV-12 with the ca. 4.9-kb plasmid from some isolates but not others and of bla CMY-2 with the ca. 130-kb plasmid from some isolates warrant further analysis, such as PCR-based replicon typing (PBRT) with subsequent sequencing, which will allow us to establish the relatedness of the plasmids identified. The Salmonella genomic island (SGI1-K) was not present, in contrast to previous reports (15) . A class 1 integron was detected in 1 of 3 CMY-2-positive isolates and in all 4 of the SHV-12-positive isolates.
The isolates were 92% similar on XbaI PFGE, with sets of 3 (type D) and 2 (type C) isolates indistinguishable. PFGE with BlnI provided limited additional discrimination between the isolates. Four isolates were from different broiler farms, with 2 isolates (different PFGE profiles) from the same broiler farm. One isolate could not be traced. All the broiler farms are stocked from one breeder farm. Comparison of PFGE patterns with archived S. Kentucky patterns suggests that this group of SHV-12-and CMY-2-producing S. Kentucky isolates is closely related to a number of pan-susceptible S. Kentucky isolates from human, poultry, and environmental samples (data not shown).
The simultaneous emergence of broad-spectrum-cephalosporin resistance associated with two distinct plasmid-encoded mechanisms (ESBL-SHV-12 and AmpC-CMY-2) in poultry in Ireland as described in this paper is a cause for concern. Previous experience indicates that such resistant Salmonella isolates in food animals are to be associated with human disease (4). The route by which these resistant mechanisms gained access to the multiple poultry farms involved is unclear, but possibilities include colonization of stock received from breeder flocks and/or inadequate biosecurity.
It is important to highlight that cephalosporins are not licensed for use in poultry production in Ireland; however, amoxicillin is used for the control of clostridia and bacterial enteritis and therefore may generate a selective pressure for possession and retention of a ␤-lactamase (4, 6, 16), as it is widely hypothesized that the introduction and persistence of ␤-lactamase-producing Salmonella on farms may be sustained due to selective pressure related to antimicrobial prescribing (16) . However, it has been demonstrated that the acquisition and persistence of plasmid-mediated ␤-lactamase in Salmonella from commensal intestinal flora can occur even in the absence of selective antimicrobial pressure (10, 19) . The exact mechanisms of dissemination and maintenance of resistance plasmids in the absence of selective pressure merit further investigation.
In conclusion, regular monitoring for Salmonella in food animals must include adequate antimicrobial susceptibility testing of isolates to ensure that new threats, such as broadspectrum-cephalosporin resistance, are recognized and addressed before they are widely disseminated. In the context of poultry farming, breeder flocks, from which other farms are stocked, require especially close monitoring because of their potential to act as foci of dissemination of antimicrobial resistance. 
